Carbatrol and Type 2 diabetes - a phase IV clinical study of FDA data

Summary:

Type 2 diabetes is found among people who take Carbatrol, especially for people who are female, 40-49 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Carbatrol and have Type 2 diabetes. It is created by eHealthMe based on reports of 1,749 people who have side effects when taking Carbatrol from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jul, 04, 2022

1,749 people reported to have side effects when taking Carbatrol.
Among them, 15 people (0.86%) have Type 2 diabetes.


What is Carbatrol?

Carbatrol has active ingredients of carbamazepine. It is often used in epilepsy. eHealthMe is studying from 1,883 Carbatrol users for its effectiveness, alternative drugs and more.

What is Type 2 diabetes?

Type 2 diabetes is found to be associated with 2,276 drugs and 1,799 conditions by eHealthMe.

Number of Carbatrol and Type 2 diabetes reports submitted per year:

Could Carbatrol cause Type 2 diabetes?

Time on Carbatrol when people have Type 2 diabetes *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Type 2 diabetes when taking Carbatrol *:

  • female: 80 %
  • male: 20 %

Age of people who have Type 2 diabetes when taking Carbatrol *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 6.67 %
  • 30-39: 26.67 %
  • 40-49: 33.33 %
  • 50-59: 26.67 %
  • 60+: 6.67 %

Common drugs people take besides Carbatrol *:

  1. Seroquel: 14 people, 93.33%
  2. Zyprexa: 9 people, 60.00%
  3. Depakote: 8 people, 53.33%
  4. Risperdal: 8 people, 53.33%
  5. Geodon: 7 people, 46.67%
  6. Topamax: 6 people, 40.00%
  7. Haldol: 6 people, 40.00%
  8. Abilify: 5 people, 33.33%
  9. Premarin: 4 people, 26.67%
  10. Trileptal: 4 people, 26.67%

Common side effects people have besides Type 2 diabetes *:

  1. Weight Loss: 4 people, 26.67%
  2. Diabetes: 4 people, 26.67%
  3. High Blood Cholesterol: 4 people, 26.67%
  4. Pancreatitis Acute (sudden inflammation of pancreas): 3 people, 20.00%
  5. Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 2 people, 13.33%
  6. Bipolar Disorder (mood disorder): 2 people, 13.33%
  7. Weight Increased: 2 people, 13.33%
  8. Hyperglycemia (high blood sugar): 2 people, 13.33%
  9. Diabetic Ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies): 2 people, 13.33%
  10. Type 1 Diabetes: 2 people, 13.33%

Common conditions people have *:

  1. Bipolar Disorder (mood disorder): 11 people, 73.33%
  2. Depression: 10 people, 66.67%
  3. Sleep Disorder: 3 people, 20.00%
  4. Stress And Anxiety: 1 person, 6.67%
  5. Affective Disorder (mental disorder): 1 person, 6.67%
  6. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 6.67%
  7. Diabetes: 1 person, 6.67%
  8. Dry Eyes (lack of adequate tears): 1 person, 6.67%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 6.67%
  10. Headache (pain in head): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Carbatrol and have Type 2 diabetes?

Check whether Type 2 diabetes is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of Carbatrol:

Type 2 diabetes treatments and more:

COVID vaccines that are related to Type 2 diabetes:

How severe was Type 2 diabetes and when was it recovered:

Expand to all the drugs that have ingredients of carbamazepine:

Common drugs associated with Type 2 diabetes:

All the drugs that are associated with Type 2 diabetes:

Common conditions associated with Type 2 diabetes:

All the conditions that are associated with Type 2 diabetes:

How the study uses the data?

The study uses data from the FDA. It is based on carbamazepine (the active ingredients of Carbatrol) and Carbatrol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: